Modular peptide recognition domains in eukaryotic signaling

Annual Review of Biophysics and Biomolecular Structure

Volumn 26, Issue , 1997, Pages 259-288

  Kuriyan, John ^a   Cowburn, David ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

PDZ; PTB; SH2; SH3; Src homology; Tyrosine kinase

Indexed keywords

PEPTIDE; PHOSPHATASE; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; TYROSINE;

AMINO ACID SEQUENCE; CATALYSIS; EUKARYOTE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 0030950608     PISSN: 10568700     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.biophys.26.1.259     Document Type: Review

References (104)

1. Abrams CS, Zhao W. 1995. SH3 domains specifically regulate kinase activity of expressed Src family proteins. J. Biol. Chem. 270:333-39
2. Alexandropoulos K, Baltimore D. 1996. Coordinate activation of c-Src by SH3-and SH2-binding sites on a novel p130Cas-related protein, Sin. Genes Dev. 10:1341-55
3. Blaikie P, Immanuel D, Wu J, Li N, Yajnik V, Margolis B. 1994. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J. Biol. Chem. 269:32031-34
4. Booker GW, Breeze AL, Downing AK, Panayotou G, Gout I, et al. 1992. Structure of an SH2 domain of the p85α subunit of phosphatidylinositol-3-OH kinase. Nature 358:684-87
5. Burley SK, Petsko GA. 1986. Amino-aromatic interactions in proteins. FEBS Lett. 203:139-43
6. Cabral JHM, Petosa C, Sutcliffe MJ, Raza S, Byron O, et al. 1996. Crystal structure of a PDZ domain. Nature 382:649-52
7. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, et al. 1991. Oncogenes and signal transduction. Cell 64:281-302
8. Case RD, Piccione E, Wolf G, Lechleider RJ, Chaudhuri M, et al. 1994. SH-PTP2 SH2 domain binding specificity is defined by direct interactions with PDGF β-receptor, EGF receptor, and IRS-1 derived phosphopeptides. J. Biol. Chem. 269:10467-74
9. Charbonneau H, Tonks NK. 1992. 1002 protein phosphatases? Annu. Rev. Cell Biol. 8:463-93
10. Cicchetti P, Mayer BJ, Theil G, Baltimore D. 1992. Identification of a protein that binds to the SH3 region of abl and is similar to Bcr and GAP-rho. Science 257:803-6
11. Clackson T, Wells JA. 1995. A hot spot of binding energy in a hormone-receptor interface. Science 267:383-86
12. Cohen B, Yoakim M, Piwnica-Worms H, Roberts T, Schaffhausen BS. 1990. Tyrosine phosphorylation is a signal for the trafficking of pp85, a polypeptide associated with phosphatidylinositol kinase activity. Proc. Natl. Acad. Sci. USA 87: 4458-62
13. Cohen GB, Ren R, Baltimore D. 1995. Modular binding domains in signal transduction proteins. Cell 80:237-48
14. Combs AP, Kapoor TM, Feng S, Chen JK, Daude-Snow LF, Schreiber SL. 1996. Protein structure-based combinatorial chemistry: discovery of non-peptide binding elements to Src SH3 domain. J. Am. Chem. Soc. 118:287-88
15. Cowburn D, Zheng J, Xu Q, Barany G. 1995. Enhanced affinities and specificities of consolidated ligands for the Src homology (SH) 3 and SH2 domains of Abelson protein-tyrosine kinase. J. Biol. Chem. 270:26738-41
16. Cussac D, Frech M, Chardin P. 1994. Binding of the GRB2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domain for Sos proline-rich motifs. EMBO J. 13:4011-21
17. Daniel MD, Kirchoff F, Czajak SC, Sehgal PK, Derosiers RC. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-41
18. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, et al. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-91
19. Doyle DA, Lee A, Lewis J, Kim E, Sheng M, MacKinnon R. 1996. Crystal structures of a complexed and peptide-free membrane protein-binding domain - molecular basis of peptide recognition by PDZ domains. Cell 85: 1067-76
20. Eck MJ, Atwell SK, Shoelson SE, Harrison SC. 1994. Crystal structure of the regulatory domains of the Src-family tyrosine kinase lck. Nature 368:764-69
21. Eck MJ, Dhepaganon S, Trub T, Nolte RT, Shoelson SE. 1996. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85:695-705
22. Eck MJ, Pluskey S, Trüb T, Harrison SC, Shoelson SE. 1996. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 379:277-80
23. Eck MJ, Shoelson SE, Harrison SC. 1993. Recognition of a high affinity phosphotyrosyl peptide by the Src homology 2 domain of p56lck. Nature 362:87-91
24. Felder S, Zhou M, Hu P, Urena J, Ullrich A, et al. 1993. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol. Cell. Biol. 13:1449-55
25. Feller SM, Ren R, Hanafusa H, Baltimore D. 1994. SH2 and SH3 domains as molecular adhesives : the interactions of Crk and Abl. Trends Biochem. Sci. 19:453-59
26. Feng S, Chen JK, Yu H, Simon JA, Schreiber SA. 1994. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266:1241-47
27. Feng S, Kasahara C, Rickles RJ, Schreiber SL. 1995. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl. Acad. Sci. USA 92:12408-15
28. Gilmer T, Rodriguez M, Jordan S, Crosby R, Alligood K, et al. 1994. Peptide inhibitors of src SH3-SH2-phosphoprotein interactions. J. Biol. Chem. 269:31711-19
29. Gosser YQ, Zheng J, Overduin M, Mayer BJ, Cowburn D. 1995. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct. Structure 3:1075-86
30. Goudreau N, Cornille F, Duchesne M, Parker F, Tocqué B, et al. 1994. NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline rich peptide from Sos. Nature Struct. Biol. 1:898-907
31. Grzesiek S, Bax A, Clore GM, Gronenborn AM, Hu J-S, et al. 1996. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Struct. Biol. 3:340-45
32. Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via novel non-SH2 domain. Mol. Cell. Biol. 15:2500-8
33. Hatada MH, Lu X, Laird ER, Green J, Morgenstern JP, et al. 1995. Molecular basis for the interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 377:32-38
34. Kavanaugh WM, Williams LT. 1994. An alternative to SH2 domains for binding tyrosine-phosphorylated growth factor receptors. Science 266:1862-65
35. Kazlauskas A, Kashishian A, Cooper JA, Valius M. 1992. GTPase activating protein and phosphatidylinositol 3-kinase bind to a distinct region of the platelet-derived growth factor receptor b subunit. Mol. Cell. Biol. 12:2534-44
36. Kestler HW III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, et al. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-62
37. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. 1995. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:259-60
38. Knudsen BS, Feller SM, Hanafusa H. 1994. Four proline-rich sequences of the guanine-nucleotide exchange factor, C3G, bind with unique specificity to the first Src homology 3 domain of Crk. J. Biol. Chem. 269:32781-87
39. Knudsen BS, Zheng J, Feller SM, Mayer JP, Burrell SK, et al. 1995. Affinity and specificity requirements for the first Src homology 3 domain of the Crk protein. EMBO J. 14:2191-98
40. Kraulis P. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946-50
41. Kuriyan J, Cowburn D. 1993. Structures of SH2 and SH3 domains. Curr. Opin. Struct. Biol. 3:828-37
42. Ladbury JE, Lemmon MA, Zhou M, Green J, Botfield MC, Schlessinger J. 1995. Measurement of the binding tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl. Acad. Sci. USA 92:3199-203
43. Lee C-H, Kominos D, Jacques S, Margolis B, Schlessinger J, et al. 1994. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure 2:423-38
44. Lee C-H, Leung B, Lemmon MA, Zheng J, Cowburn D, et al. 1995. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14:5006-15
45. Lee C-H, Saksela K, Mirza UA, Chait BT, Kuriyan J. 1996. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85:931-42
46. Lemmon MA, Ladbury JE. 1994. Thermodynamic studies of tyrosyl-phosphopeptide binding to the SH2 domain of p56lck. Biochemistry 33: 5070-76
47. Lemmon MA, Ladbury JE, Mandiyan V, Zhou M, Schlessinger J. 1994. Independent binding of peptide ligands to the SH2 and SH3 domains of GRB2. J. Biol. Chem. 269:31653-58
48. Lim WA, Richards FM. 1994. Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition. Nature Struct. Biol. 1:221-25
49. Lim WA, Richards FM, Fox RO. 1994. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372:375-79
50. Macias MJ, Hyvönen M, Baraldi E, Schultz J, Sudol M, et al. 1996. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 382:646-49
51. Maignan S, Guilloteau J-P, Fromage N, Arnoux B, Becquart J, Ducruix A. 1995. Crystal structure of the mammalian GRB2 adaptor. Science 268:291-93
52. Marengere LEM, Songyang Z, Gish GD, Schaller MD, Parsons JT, et al. 1994. SH2 domain specificity and activity modified by a single residue. Nature 369:502-5
53. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D. 1992. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming ability in vivo. Mol. Cell. Biol. 12:609-18
54. Mitchell JBO, Nandi CL, Ali S, McDonald IK, Thornton JM, et al. 1993. Amino/aromatic interactions. Nature 366:413
55. Moran MF, Koch CA, Anderson D, Ellis C, England L, et al. 1990. Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. USA 87:8622-26
56. Musacchio A, Noble M, Pauptit R, Wierenga R, Saraste M. 1992. Crystal structure of a Src-homology 3 (SH3) domain. Nature 359:851-55
57. Musacchio A, Saraste M, Wilmanns M. 1994. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nature Struct. Biol. 1:546-51
58. Narula SS, Yuan RW, Adams SE, Green OM, Green J, et al. 1995. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Structure 3:1061-73
59. Nolte RT, Eck MJ, Schlessinger J, Shoelson SE, Harrison SC. 1996. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nature Struct. Biol. 3:364-73
60. Overduin M, Rios CB, Mayer BJ, Baltimore D, Cowburn D. 1992. Three-dimensional solution structure of the src homology 2 domain of c-abl. Cell 70:697-704
61. Panayotou G, Bax B, Gout I, Federwisch M, Wroblowski B, et al. 1992. Interaction of the p85 subunit of PI 3-kinase and its N-terminal SH2 domain with a PDGF receptor phosphorylation site: structural features and analysis of conformational changes. EMBO J. 11:4261-72
62. Panayotou G, Gish G, End P, Truong O, Gout I, et al. 1993. Interactions between SH2 domains and tyrosine phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach. Mol. Cell. Biol. 13:3567-76
63. γ1 complexed with a high affinity binding peptide. Cell 77:461-72
64. Pascal SM, Yamazaki T, Singer AU, Kay LE, Forman-Kay JD. 1995. Structural and dynamic characterization of the phosphotyrosine binding region of a Src homology 2 domain-phosphopeptide complex by NMR relaxation, proton exchange and chemical shift approaches. Biochemistry 34:11353-62
65. Pawson T. 1988. Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. Oncogene 3:491-95
66. Pawson T. 1995. Protein modules and signalling networks. Nature 373:573-80
67. Pawson T, Schlessinger J. 1993. SH2 and SH3 domains. Curr. Biol. 3:434-42
68. Payne G, Shoelson SE, Gish GD, Pawson T, Walsh CT. 1993. Binding kinetics of Lck and Src SH2 domain/phosphopeptide interactions by competition assay and surface plasmon resonance. Proc. Natl. Acad. Sci. USA 90:4902-6
69. Rahuel J, Gay B, Erdmann D, Strauss A, Garcia-Echeverria C, et al. 1996. Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode. Nature Struct. Biol. 3:586-89
70. Ren R, Mayer BJ, Cicchetti P, Baltimore D. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157-61
71. Rety S, Futterer K, Grucza RA, Munoz CM, Frazier WA, Waksman G. 1996. pH dependent self-association of the Src homology-2 (SH2) domain of the Src homologous and collagen-like (SHC) protein. Protein Sci. 5:405-13
72. Rosen MK, Yamazaki T, Gish GD, Kay CM, Pawson T, Kay LE. 1995. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374:477-79
73. Roussel RR, Brodeur SR, Shalloway D, Laudano AP. 1991. Selective binding of activated pp60 c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60 c-src. Proc. Natl. Acad. Sci. USA 88:10696-700
74. Sadowski I, Stone JC, Pawson T. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of fujinami sarcoma virus p130gag-fps. Mol. Cell. Biol. 6:4396-408
75. + viruses but not for down-regulation of CD4. EMBO J. 14:484-91
76. Shoelson SE, Sivaraja M, Williams KP, Hu P, Schlessinger J, Weiss MA. 1993. Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation. EMBO J. 12:795-802
77. Sicheri F, Moarefi I, Kuriyan J. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385:602-9
78. Songyang Z, Cantley LC. 1995. Recognition and specificity in protein tyrosine kinase-mediated signalling. Trends Biochem. Sci. 20:470-75
79. Songyang Z, Gish G, Mbamulu G, Pawson T, Cantley LC. 1995. A single point mutation switches the specificity of group III src homology (SH) 2 domains to that of group I SH2 domains. J. Biol. Chem. 270:26029-32
80. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-78
81. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, et al. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk and Vav. Mol. Cell. Biol. 14:2777-85
82. Stanfield RI, Wilson IA. 1995. Protein-peptide interactions. Curr. Opin. Struct. Biol. 5:103-13
83. Sudol M, Chen HI, Bougeret C, Bork P. 1995. Characterization of a novel protein-binding modular - the WW domain. FEBS Lett. 369:67-71
84. Superti-Furga G, Courtneidge SA. 1995. Structure-function relationships in Src family and related protein kinases. Bioessays 17:321-30
85. Superti-Furga G, Fumagalli S, Koegl M, Courtneidge SA, Draetta G. 1993. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12:2625-43
86. Talmadge DA, Freund R, Young AT, Dahl J, Dawe CJ, Benjamin TL. 1989. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Cell 59:55-65
87. Terasawa H, Kohda D, Hatanaka H, Tsuchiya S, Ogura K, et al. 1994. Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos. Nature Struct. Biol. 1:891-97
88. Tong L, Warren TC, King J, Betageri R, Rose J, Jakes S. 1996. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 Å and 1.8 Å resolution. J. Mol. Biol. 256:601-10
89. Trono D. 1995. HIV accessory proteins: leading roles for the supporting cast. Cell 82:189-92
90. Valius M, Bazenet C, Kazlauskas A. 1993. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β subunit and are required for binding of phospholipase Cy and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 13:133-43
91. Waksman G, Kominos D, Robertson SR, Pant N, Baltimore D, et al. 1992. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358:646-53
92. Waksman G, Shoelson SE, Pant N, Cowburn D, Kuriyan J. 1993. Binding of a high affinity phophotyrosyl peptide to the src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72:779-90
93. Wange RL, Malek SN, Desiderio S, Samelson LE. 1993. Tandem SH2 domains of ZAP-70 bind to T-cell antigen receptor zeta and CD3 epsilon J. Biol. Chem. 268:19797-801
94. Weiss A. 1993. T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73:209-12
95. Whitman M, Kaplan DR, Schaffhausen B, Cantley L, Roberts TM. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239-42
96. Wu X, Knudsen B, Feller SM, Zheng J, Sali A, et al. 1995. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3:215-26
97. Xu W, Harrison SC, Eck MJ. 1997. Nature 385:595-602
98. Xu RX, Word JM, Davis DG, Rink MJ, Willard DH Jr., Gampe RT Jr. 1995. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide. Biochemistry 34:2107-21
99. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76:933-45
100. Yu H, Rosen MK, Shin TB, Seidel-Duggan C, Brugge JS, Schreiber SL. 1992. Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science 258:1665-68
101. Zhou M-M, Huang B, Olejniczak ET, Meadows RP, Shuker SB, et al. 1996. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nature Struct. Biol. 3:388-93
102. Zhou MM, Meadows RP, Logan TM, Yoon HS, Wade WS, et al. 1995. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc. Natl. Acad. Sci. USA 92:7784-88
103. Zhou MM, Ravichandran KS, Olejniczak EF, Petros AM, Meadows RP, et al. 1995. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 378:584-92
104. Zvelebil MJJM, Panayotou G, Linacre J, Waterfield MD. 1995. Prediction and analysis of SH2 domain-phosphopeptide interactions. Protein Eng. 8:527-33